Testing the Cognitive Facilitation Effect by Dietary Supplementation of MelaGene+ Drink

TCI

Status: Completed

Conditions: Cognitive Change

Treatments: Dietary Supplement: MelaGene+; Dietary Supplement: placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT05988593

CMUH111-REC3-127

Details and patient eligibility

About

To assess the efficacy of MelaGene+ on cognitive performance

Enrollment: 64 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 20 to 65-year-old males or females

Exclusion criteria

• Participants are breastfeeding, pregnant or planning to become pregnant during the test (self-report)
• Participants with heart, liver, kidney, endocrine and other major organic diseases (self-reported)
• Participants take drugs for a long time (self-report)
• Participants with mental illness or have undergone brain surgery
• Participants still can not clearly see words with 12pt on computer after corrected vision

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

64 participants in 2 patient groups, including a placebo group

placebo drink

Placebo Comparator group

Treatment:

Dietary Supplement: placebo

MelaGene+

Experimental group

Treatment:

Dietary Supplement: MelaGene+